William Byrnes

Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial

Wendy Waldman Zadeh, Antonio Escartín, William Byrnes et al. · Seizure · 2015 · 50 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Randomized double-blind comparison of cognitive and EEG effects of lacosamide and carbamazepine

Kimford J. Meador, David W. Loring, Alan Boyd et al. · Epilepsy & Behavior · 2016 · 33 citations

Medicine, Neurology, Pharmacology +11

Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures – An open-label trial

José Alexandre Ferreira, Jean‐Baptiste Le Pichon, Ahmed Abdelmoity et al. · Seizure · 2019 · 28 citations · Full text

Medicine, Pediatrics, Pharmacology +12

Efficacy and safety of adjunctive padsevonil in adults with drug‐resistant focal epilepsy: Results from two double‐blind, randomized, placebo‐controlled trials

Michael Rademacher, Manuel Toledo, Wim Van Paesschen et al. · Epilepsia Open · 2022 · 27 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Long‐term exposure and safety of lacosamide monotherapy for the treatment of partial‐onset (focal) seizures: Results from a multicenter, open‐label trial

David G. Vossler, Robert Wechsler, Paulette Williams et al. · Epilepsia · 2016 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15